Tag: Astrazeneca
AstraZeneca: Alexion will present 11 summaries of its progress
[ad_1] (CercleFinance.com) – AstraZeneca announces that Alexion, its division dedicated to rare diseases, will present data on its portfolio of treatments for generalized myasthenia gravis (gMG) at the annual meeting…
AstraZeneca: FDA approves application for Enhertu
[ad_1] (CercleFinance.com) – AstraZeneca announces that the supplemental biological license application (sBLA) for Enhertu has been accepted with priority review by the FDA to treat unresectable or metastatic HER2-low or…
AstraZeneca: Collaboration with the start-up Immunai on AI
[ad_1] Receive the value of the day for free every morning The data collected is essential for this processing and is intended for the relevant services of BFM Bourse and,…
AstraZeneca: new approval for Tagrisso in the USA
[ad_1] (CercleFinance.com) – AstraZeneca announced Thursday that the US FDA had approved the use of its Tagrisso for the treatment of patients with inoperable stage 3 non-small cell lung cancer…
AstraZeneca: Disappointment over Dato-DXd in breast cancer
[ad_1] (CercleFinance.com) – AstraZeneca announced Monday that a phase III clinical trial evaluating an experimental antibody-drug conjugate in breast cancer had not shown statistical significance in terms of overall survival,…
AstraZeneca: disappointment over Dato-DXd in breast cancer
[ad_1] (CercleFinance.com) – AstraZeneca announced Monday that a phase III clinical trial evaluating an experimental antibody-drug conjugate in breast cancer had not shown statistical significance in terms of overall survival,…
AstraZeneca: several positive results in cancer
[ad_1] (CercleFinance.com) – AstraZeneca reported positive results for several cancer studies on Monday at the annual congress of the European Society for Medical Oncology (ESMO), currently taking place in Barcelona.…
AstraZeneca: Deutsche Bank goes ‘sale’
[ad_1] (CercleFinance.com) – Deutsche Bank announced on Friday that it had downgraded its recommendation on AstraZeneca shares to ‘sell’, from ‘hold’ until now, with a price target reduced from 11,000…
AstraZeneca: Deutsche Bank goes ‘sale’
[ad_1] (CercleFinance.com) – Deutsche Bank announced on Friday that it had downgraded its recommendation on AstraZeneca shares to ‘sell’, from ‘hold’ until now, with a price target reduced from 11,000…
AstraZeneca: share price drops, clinical trial unconvincing
[ad_1] (CercleFinance.com) – AstraZeneca shares fell in early trading on the London Stock Exchange on Tuesday, as the pharmaceutical company revealed the results of a clinical study in the treatment…
AstraZeneca: Shares fall, clinical trial unconvincing
[ad_1] (CercleFinance.com) – AstraZeneca shares fell in early trading on the London Stock Exchange on Tuesday, as the pharmaceutical company revealed the results of a clinical study in the treatment…
AstraZeneca: FDA grants priority review for Imfinzi
[ad_1] Published on 08/15/2024 at 12:09 p.m. Photo credit © Reuters (Reuters) – AstraZeneca said on…